Identification of Patients with a Histologically Unstable Carotid Plaque Using Ultrasonic Plaque Image Analysis  by Salem, M.K. et al.
Identiﬁcation of Patients with a Histologically Unstable Carotid Plaque Using
Ultrasonic Plaque Image Analysis
M.K. Salem a,*, M.J. Bown a,b, R.D. Sayers a, K. West c, D. Moore c, A. Nicolaides d,e, T.G. Robinson b, A.R. Naylor a
a Department of Cardiovascular Sciences, University of Leicester, Leicester, UK
b NIHR Leicester Cardiovascular Biomedical Research Unit, Leicester, UK
c Department of Histopathology, University Hospitals Leicester, Leicester, UK
d Department of Surgery, St George’s University of London, London, UK
e University of Nicosia Medical School, Nicosia, Cyprus* Cor
Cardiov
Leicest
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
If validated, it may be possible to identify patients with a higher or lower likelihood of having a histologically
unstable plaque using readily accessible ultrasound images and plaque software analysis.Objectives: In patients with carotid stenosis the risk of stroke is highest in the ﬁrst few days after onset of
symptoms and it is low in asymptomatic patients. The ability to identify patients with a high (or low) probability
of having a histologically unstable plaque might become a complimentary method that can reﬁne the indications
for surgical intervention.
Methods: Two histopathologists, using validated American Heart Association criteria, independently graded
plaques harvested during carotid endarterectomy. Preoperative Duplex images were independently assessed for
juxtaluminal black area, plaque type, plaque area, and grey-scale median (GSM) following image normalization.
Logistic regression analysis was then performed to create a model for predicting predominantly histologically
unstable or stable plaques.
Results: A total of 126 patients were included in the study. Based on the presence and extent of histological
features including haemorrhage, thrombus, ﬁbrous tissue, lipid core, inﬂammation, neovascularity, foam cells,
and cap rupture, 39 plaques were graded as predominantly stable, while 87 were predominantly unstable.
Unstable plaques were associated with a plaque area >95 mm2 (OR 4.15; 95% CI 1.34e12.8 p ¼ .009), a
juxtaluminal black area >6 mm2 (OR 2.77; 95% CI 1.24 to 6.17 p ¼ .01) and a GSM <25 (OR 3.76; 95% CI 1.14e
12.39). Logistic regression indicated that patients with the ﬁrst two features had a 90% probability of having a
histologically unstable plaque. The model was used to calculate the probability of having an unstable plaque in
each patient. The receiver operating characteristic curve using the p value was 0.68 (95% CI 0.59e0.78).
Conclusions: Computerized plaque analysis has the potential to identify patients with histologically unstable
carotid plaques. This model requires validation, but offers the potential to inﬂuence patient selection for
emergency interventions and the monitoring of medical therapy.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Guidelines1,2 for treating patients with carotid artery dis-
ease rely primarily on stenosis severity and clinical symp-
toms. The majority of strokes in patients with moderate to
severe carotid stenoses are caused by thromboembolism
from an unstable carotid plaque,3 deﬁned as having several
of the following features: thinned/ruptured cap, large lipid
core, intraplaque haemorrhage, surface thrombus, cap/responding author. M.K. Salem, Vascular Surgery Group, Division of
ascular Sciences, Robert Kilpatrick Clinical Sciences Building,
er Royal Inﬁrmary, Leicester LE2 7LX, UK.
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//dx.doi.org/10.1016/j.ejvs.2014.05.015plaque inﬂammation, and marked neovascularization.4,5
These features (especially dense macrophage inﬂamma-
tion) were recently shown to be associated with a high risk
of early recurrent stroke in patients with 50e99% stenoses,
leading the authors to recommend that imaging strategies
be developed for identifying patients with unstable plaque
features.6
Computed tomography (CT),7,8 magnetic resonance im-
aging (MRI),9 positron emission tomography (PET), and
infrared spectroscopy10 have been used to identify the
“unstable plaque”. Whilst showing reasonable concordance
with histological ﬁndings, most are not as accessible as ul-
trasound. In earlier ultrasound studies, hypoechoic plaques
(Types 1 and 2) were associated with symptoms.11,12 More
recent studies using ultrasound and plaque characterization
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tures that were independent predictors of future cerebro-
vascular events. It was hypothesized that these might
enable risk stratiﬁcation in patients with asymptomatic ca-
rotid stenosis.13,14 These features included; low grey scale
median (GSM), larger plaque area, and the presence/size of
the juxtaluminal plaque area. When the same scrutiny was
applied to images of plaques from symptomatic patients, it
identiﬁed a subgroup with a higher rate of recurrent tran-
sient ischaemic attacks (TIAs) whilst awaiting surgery.15
The aim of this study was to determine the association
between ultrasound-derived plaque features and histologi-
cal plaque instability. We hypothesized that the ability to
identify a high (or low) probability of unstable plaque might
provide an alternative (and accessible) method for planning
the nature and urgency of carotid interventions, as well as
being a means of monitoring the effects of medical therapy
on plaque morphology in other patient cohorts.METHODS
Consecutive patients undergoing carotid endarterectomy
(CEA) between August 2008 and March 2010 were included
after giving informed consent. The study was authorized by
the Leicestershire, Northamptonshire, and Rutland Ethics
Committee. Patients were included if they were recently
symptomatic (<6 months) with a 50e99% NASCET steno-
sis,16 or asymptomatic with a 70e99% stenosis.
Symptomatic patients were admitted directly from the
daily TIA Clinic or from the Stroke Unit. Symptomatic pa-
tients were started on 300 mg of aspirin and 40 mg ofFigure 1. (A) “Unstable” plaque detected on ultrasound analysis. Juxtalu
bright red areas within the black lumen. (B) “Stable” plaque features d
white. DWAs are bright red areas within the black lumen.simvastatin prior to transfer, and these medications were
continued throughout the peri-operative period. In addi-
tion, all patients received 75 mg of clopidogrel the night
before surgery.17 A fuller description of the reconﬁgured TIA
clinic has been published elsewhere.18 CEA was performed
as soon as possible after the index event. Asymptomatic
patients were started on medical therapy in the outpatient
department. Most had been taking aspirin, statin, and anti-
hypertensive therapy for at least 4 weeks prior to surgery.
Duplex imaging
Accredited ultrasonographers performed the duplex exam-
inations using an ATL HDI5000 ultrasound scanner and an
L12e5 linear array probe (Philips Medical Systems, Andover,
MA, USA). Stenosis severity was measured using NASCET-
derived measurement criteria.16 In addition to grading
stenosis severity, B-mode longitudinal unenhanced images
of the plaque were obtained with and without colour
ﬂow.14,19 Image analysis was then performed by a single
investigator (A.N.) who was completely blinded to all clinical
and histological data.
Image normalization and measurements of GSM and JBA
(see Fig. 1a,b)
Image analysis was performed using the “Plaque Texture
Analysis software” (LifeQ Medical, 66 Metochiou, Engomi,
2407, Cyprus; www.lifeqmedical.com), which is a dedicated
software package.14 Image normalization was performed so
that the area representing blood had a grey scale of zero,
whilst the brightest area of adventitia had a grey scale ofminal black area outlined in white. Discrete white areas (DWAs) are
etected on ultrasound analysis. Juxtaluminal black area outlined in
120 M.K. Salem et al.190. This was achieved by selecting a sample of “blood”
from the vessel lumen avoiding areas of “noise” and then
the middle two-fourths of the brightest part of the adven-
titia adjacent to the plaque.Ultrasound-derived plaque features
Grey-scale median.Median of the grey values of all pixels in
the plaque image.19
Plaque type (computer derived).Figure
thromType 1. Uniformly echolucent (black): <15% of the
pixels in the plaque area were occupied by pixels with
grey scale values >25.
Type 2. Mainly echolucent: pixels with grey scale
values >25 occupy 15e50% of the plaque area.
Type 3. Mainly echogenic: pixels with grey scale
values >25 occupy 50e85% of the plaque area.
Type 4/5. Uniformly echogenic: pixels with grey scale
values >25 occupy >85% of the plaque area.11,12Plaque area (mm2). Calculated by the imaging software
using distance scale on the side of the image frame for
calibration and the plaque area outlined by the operator.
Juxtaluminal black areas (Fig. 1a,b). The juxtaluminal black
area (JBA) (deﬁned as the area adjacent to the lumen with
pixels which after image normalization had a grey scale <25
without a visible echogenic cap) was outlined and the area
automatically calculated. If there were >2 discrete JBAs, the
larger value was used in the analyses. A large JBA has been
previously associated with a high prevalence of symptom-
atic plaques in all grades of stenosis.20Carotid endarterectomy
Carotid endarterectomy was performed under general
anaesthesia with routine patching, routine shunting,2. Unstable plaque on haematoxylin and eosin staining showin
bus (ST) (10) and histological grading.systemic heparinization (unfractionated) and distal intimal
tacking sutures. Endarterectomy was performed via a lon-
gitudinal arteriotomy and the plaque removed with the
minimum of trauma. The lumen of the endarterectomized
segment of artery was inspected using an angioscope prior
to restoration of ﬂow.
Histopathology
Plaques harvested during CEA were divided longitudinally.
One half was immediately ﬁxed in formalin for 24 hours and
then parafﬁn embedded. A 5-mm transverse section was
taken from the parafﬁn block and stained using haema-
toxylin and eosin. Histological sections were analysed by
two independent histopathologists (K.W., D.M.) who were
completely blinded to the clinical and ultrasound ﬁndings.
For each plaque (Fig. 2), a semi-quantitative 3- or 4-point
score (Table 1) was assigned to assess the presence and/
or amount of features of plaque instability, based on the
AHA histological classiﬁcation.4,21 Based on number of un-
stable/stable features the plaque was subjectively scored by
each histopathologist independently as overall predomi-
nantly stable or unstable. Where a difference was noted
between scores, slides were placed on a large screen, and
agreement reached after discussion.
Statistical analyses
The association between ultrasound-derived features (ste-
nosis, GSM, plaque area, JBA, plaque type) and histologi-
cally unstable/stable plaques was investigated by calculating
the odds ratio for each group of the nominal variables or
quartiles of the continuous variables. On the basis of the
signiﬁcant associations found between features, the cut-off
points for the upper quartiles were then used to reclassify
each of these features into two classes. These signiﬁcant
plaque features were then entered as dichotomous vari-
ables into a multivariable logistic regression with the his-
tological classiﬁcation as the dependent variable using theg cap rupture (arrow), intraplaque haemorrhage (IPH) and surface
Table 2. Demographics for patients with histologically stable and
unstable plaques.
Patient demographics Stable
N ¼ 39
(31%)
Unstable
N ¼ 87
(69%)
p Value
Male 23 (59%) 65 (75%) .09
Age (median) 73 (48e90) 72 (66e96) .97
Hypercholesterolaemiaa 29 (74%) 66 (76%) >.99
Diabetes mellitus 10 (26%) 16 (18%) .35
Ischaemic heart diseaseb 5 (13%) 24 (28%) .11
Hypertensionc 30 (77%) 55 (87%) .15
Ex/current smoker 30 (77%) 63 (72%) .67
On anti-platelet
therapy following admission
39 (100%) 87 (100%) >.99
On statin therapy following
admission
39 (100%) 87 (100%) >.99
Symptomatic 31 (79%) 73 (83%) .80
a On treatment by family GP/Hospital doctor for raised cholesterol
levels.
b Angiography/ECG/Biochemistry proven evidence of coronary
artery disease and on treatment.
c On treatment for hypertension initiated by GP/Hospital doctor.
Table 1. Semi-quantitative scoring system for histological carotid plaque grading.19
Histological feature Grade 0 Grade 1 Grade 2 Grade 3
Haemorrhage No haemorrhage Small haemorrhage Large haemorrhage e
Thrombus No thrombus Small thrombus Large thrombus e
Lipid core No lipid core Small lipid core Large lipid core e
Fibrous tissue Very little ﬁbrous
tissue
Approx. 50%
ﬁbrous tissue
Predominantly
ﬁbrous tissue
e
Chronic plaque inﬂammation None Occasional cells
or one group 50
2e5 groups 50 5 groups 50 or
1 group 500
Chronic cap inﬂammation None <10 cells in cap 10e50 cells in cap 50 cells in cap
Acute plaque inﬂammation None Occasional cells
or one group 50
2e5 groups 50 >5 groups 50 or
1 group 500
Acute cap inﬂammation None <10 cells in cap 10e50 cells in cap 50 cells in cap
Foam cells None <50 cells 50 cells e
Neovascularity None <10/section 10/section e
Cap rupture Intact Probably intact Probably ruptured Deﬁnitely ruptured
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dent predictors were used as a ﬁnal model to predict the
probability of having an unstable plaque for each patient. A
receiver operating characteristic (ROC) curve was then
produced using calculated probability. Finally, a 2  2 table
was constructed using the signiﬁcant independent variables
to classify patients into four groups. The prevalence of un-
stable plaques was determined for each of the four groups
of patients. The signiﬁcance of the prevalence was then
tested using the chi-square test and its magnitude using the
odds ratio and 95% CI.
RESULTS
One hundred and sixty-nine patients were considered for
inclusion. Twenty images from the initial part of the study
were of insufﬁcient quality for computerized plaque analysis
due to problems associated with image acquisition (ultra-
sound beam at incorrect angle, too much noise in lumen,
inadequate visualization of the plaque and adjacent
adventitia). An additional 13 images were lost during data
transfer. Ten patients were excluded as histology was un-
obtainable. This left 126 patients for inclusion (TIA/
monocular blindness, 75; stroke, 29; asymptomatic, 22).
Forty-nine of 104 symptomatic patients (47%) underwent
CEA <7 days after their most recent clinical event; 32 (31%)
<8e14 days, 12 (12%) <15e28 days, while >29 days had
elapsed in 11 patients (11%). This, therefore, provided a
broad spectrum of patients with regard to delays to surgery
(<14 days, n ¼ 81), intermediate (15e28 days, n ¼ 12), late
(>29 days, n ¼ 11) and asymptomatic (n ¼ 22). Patient
demographics (Table 2) were well matched among patients
who were found to have predominantly unstable plaques,
compared to those with predominantly stable plaque fea-
tures. The kappa value for interobserver variation between
the two histopathologists was 0.93 (95% CI 0.85e0.99).
Table 3 shows that GSM <25, plaque area >95 mm2, and
a JBA >6 mm2 were associated with an increased preva-
lence of unstable plaque features. Stenosis and Geroulakos
plaque types were not associated with plaque instability. On
the basis of the cut-off points provided by the upper
quartiles of GSM and plaque area, and median JBA, a newtable was constructed (Table 4) which shows the magnitude
of the association. A multivariate logistic regression using
the histological classiﬁcation as the dependent variable and
GSM, plaque area, and JBA as dichotomous explanatory
variables using the backward elimination method showed
that only plaque area >95 mm2 and a JBA >6 mm2 were
statistically signiﬁcant independent predictors of the pres-
ence of a histologically unstable plaque. The model in
Table 5 is a predictive model using only the above signiﬁ-
cant variables. This model was used to calculate the prob-
ability of having an unstable plaque for each patient. The
ROC curve using the value of p was 0.68 (95% CI 0.59e
0.78).
Table 6 shows the prevalence of unstable plaques in the
four groups of patients deﬁned by the dichotomous vari-
ables: plaque area and JBA. When plaque area is <95 mm2,
the presence of a JBA >6 mm2 increases the prevalence of
unstable plaques from 53% (when it is absent) to 76%. It
also shows that when the JBA is <6 mm2 the presence of a
Table 3. Odds ratios and 95% CI of unstable plaques in quartiles or groups of the ultrasonic features.
Ultrasonic measurement Range of measurement Patients studied N Unstable plaque N (%) p OR (95% CI)
Stenosis (%)
Three groups according to duplex grading
1 50e79 53 37 (70%)
2 80e89 34 22 (65%) .619 0.79 (0.32 to 1.98)
3 90e99 39 28 (72%) .83 1.10 (0.44 to 2.74)
p for trend ¼ .879
GSM
Quartiles
1 0e24 31 26 (84%) .030 3.76 (1.14 to 12.39)
2 25e37 36 24 (67%) .469 1.44 (0.53 to 3.90)
3 38e49 28 19 (68%) .43 1.52 (0.52 to 4.43)
4 50e93 31 18 (58%)
p for trend [ .044
Plaque area (mm2)
Quartiles
1 0e27 31 17 (55%)
2 28e50 32 22 (69%) .258 1.81 (0.65 to 5.07)
3 51e95 33 22 (67%) 334 1.65 (0.60 to 4.53)
4 96e178 30 26 (87%) .010 5.35 (1.50 to 19.03)
p for trend [ .015
JBA (mm2)
Quartiles
1 0e2.0 37 21 (57%)
2 2.1e6.0 29 18 (62%) .663 1.25 (0.46 to 3.36)
3 6.1e14.0 31 25 (81%) .040 3.17 (1.05 to 9.58)
4 14.1e48 39 23 (80%) .058 2.92 (0.96 to 8.85)
p for trend [ .015
Plaque type
Hyperechoic 3 and 4 90 58 (64%) e
Hypoechoic 1 and 2 36 29 (80%) .082 2.29 (0.90 to 5.80)
122 M.K. Salem et al.plaque area >95 mm2 increases the prevalence of unstable
plaques from 53% (when it is absent) to 85%. In patients
with a plaque area >95 mm2 and a JBA >6 mm2, the
prevalence of unstable plaque was 90%.
DISCUSSION
Guidelines1,2 for the management of symptomatic carotid
artery disease are primarily based upon evidence from
meta-analyses of randomized trials showing that CEA con-
fers signiﬁcant beneﬁt over medical therapy. Subgroup an-
alyses have shown that the highest risk of stroke is in the
very early time period after onset of symptoms.22,23 Pa-
tients suffering recurrent stroke (within hours/days of the
index event) have recently been found to have histological
features associated with plaque instability (especially denseTable 4. Odds ratios and 95% CI of unstable plaques in the reclassiﬁe
Ultrasonic measurement Range of
measurement
Patients
studied N
GSM
25 0e25 95
>25 26e93 31
Plaque area (mm2)
95 0e95 94
>95 96e178 32
JBA (mm2)
6 0e6.0 66
>6 6.1e48 60macrophage inﬂammation).6 To date, easily accessible and/
or reliable methods for predicting the likelihood of plaque
instability have not been immediately available. In asymp-
tomatic patients, randomized trials have shown that CEA
does confer beneﬁt (although much less than in symp-
tomatic patients), though there is emerging evidence that
improvements in medical therapy may have reduced the
average annual rate of sroke.24
Notwithstanding the beneﬁts conferred by CEA, the
randomized trials have shown that the majority of patients
were never actually destined to suffer a stroke (88% of
asymptomatic patients with 60e99% stenoses were stroke
free at 5 years; 84% of symptomatic patients with 70e99%
stenoses were stroke free at 5 years). Accordingly, there has
been considerable interest in developing imaging criteriad groups of the ultrasonic features.
Unstable
plaque N (%)
p OR (95% CI)
61 (64%)
26 (84%) .040 2.90 (1.02 to 8.24)
59 (63%)
28 (87%) .009 4.15 (1.34 to 12.83)
39 (59%)
48 (80%) .011 2.77 (1.24 to 6.17)
Table 5. Final linear logistic regression model using the signiﬁcant
features plaque area and JBA with presence of unstable plaques as
the dependent variable.
Variable b OR (95% CI) p Value
JBA (6 or >6 mm2) 0.931 2.54 (1.12 to 5.75) .026
Plaque area
(95 or >95)
1.327 3.77 (1.20 to 11.84) .023
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to target CEA or stenting. Conversely, if it were possible to
identify “low risk for stroke” patients, they might be better
treated medically and kept under surveillance.
Histological characterization can identify features associ-
ated with plaque instability, but there has been inconsistent
correlation between preoperative imaging and post-
operative plaque analysis.25,26 Contrast-enhanced ultra-
sound (CEUS) has been used to detect intraplaque
neovascularization.27,28 A recent review of six CEUS studies
with correlation against histological features demonstrated
good correlation between CEUS and histological diagnoses
of neovascularization.29 An MRI diagnosis of intraplaque
haemorrhage (IPH) has also shown positive correlation be-
tween recurrent clinical events30 and increased thrombo-
embolic activity.31 There is also evidence that an MRI
diagnosis of IPH may identify asymptomatic patients with a
higher risk of late stroke.32 Preoperative MRI and histolog-
ical correlation with “vulnerable” plaque features (including
intraplaque haemorrhage, large lipid core, and ﬁbrous cap)
have shown good sensitivity and speciﬁcity, but the tech-
nique has had limited clinical applications outside the
research environment.7,33 Not surprisingly, therefore,
evidence-based guidelines do not include any role for so-
phisticated imaging techniques for guiding patient
selection.
By contrast, Duplex ultrasound is accessible, especially in
the outpatient setting. In this study, ultrasound imaging
features on univariate analysis that signiﬁcantly predicted
an unstable carotid plaque included: an echolucent plaque
(GSM <25), a large juxtaluminal black area (>6 mm2), and a
large plaque area (>95 mm2). Geroulakos plaque Types 1
and 2 showed a trend towards plaque instability, but did not
reach statistical signiﬁcance. Following multivariate analysis,Table 6. The prevalence of histologically unstable plaques shown in
bold in the 4 groups (cells a, b, c, and d) deﬁned by Plaque Area
and JBA.
JBA <6 mm2 JBA >6 mm2
Plaque area >95 mm2 11 (85%)
N ¼ 13 c
17 (90%)
N ¼ 19 d
Plaque area <95 mm2 28 (53%)
N ¼ 53 a
31 (76%)
N ¼ 41 b
Comparison p (chi square) OR 95% CI
a vs. b .023 2.77 1.32 to 6.77
a vs. c .037 4.91 0.99 to 24.33
a vs. d .005 7.59 1.59 to 36.16
b vs. d .212 2.74 0.53 to 13.98
c vs. d .683 1.54 0.19 to 12.64only two ultrasound texture features remained signiﬁcantly
associated with an increased risk of having a histologically
unstable plaque: (a) large plaque area (95 mm2) and (b) a
large JBA (6 mm2). These two features were also inde-
pendent predictors for stroke in a recently published natural
history study (ACSRS) involving 1,121 patients with
asymptomatic carotid stenosis followed up for a mean of 4
years. When combined with degree of stenosis, these pla-
que features were able to stratify the annual risk of stroke
in different asymptomatic patient cohorts from 0.5% to
10%.13,14 This study has demonstrated that a plaque with a
low GSM is dangerous but if the plaque area with low GSM
is close to the lumen it is far more dangerous, so much
more dangerous that GSM does not add more to the pre-
diction of a histologically unstable plaque. In addition, for
two plaques producing the same degree of stenosis, the
longer one which has a larger area on a longitudinal ultra-
sound image is associated with a higher risk than the plaque
with a shorter length (smaller area) producing a localized
stenosis.
Clinical scoring methods for predicting early risk of stroke
following TIA/minor stroke include the ABCD2 score
(maximum score 7),34 the Essen Stroke Risk Score (ESRS) (9-
point system)35 and the Stroke Prognosis Instrument II (SPI-
II) score (15-point system).36 All have a predictive value in
patients who present with a TIA/minor stroke, though lim-
itations have been found, including poor short-term pre-
dictive value (ESRS and SPI-II) and not being speciﬁc to
patients with a critical carotid artery stenosis (all).
The combination of carotid imaging and brain infarction
has improved the prediction of early recurrent stroke. Giles
et al.37 showed that even with a high ABCD2 score (6e7),
the risk of stroke at 7 days was only 3.3% in patients who
had no evidence of infarction on neuroimaging, compared
with 15% in patients who had a high ABCD2 score and
recent infarction. Merwick et al.38 demonstrated that the
presence of a 50e99% carotid stenosis in combination with
abnormal diffusion-weighted imaging increased the likeli-
hood of stroke following TIA. One limitation of Merwick’s
study was that insufﬁcient statistical power existed for lo-
gistic regression of carotid imaging at 2 and 7 days, because
relatively few patients underwent carotid imaging at this
very early time period.
One of the limitations of the current study was that 20
images were not of sufﬁcient quality. These images were
taken during the earliest part of the study and reﬂect a
learning curve (noise, angle of beam, and plaque area).
After our technologists went through a 30-minute online
study module, 100% of images were used in the study.
Ultrasonography, performed by well-trained, experienced
technologists, can provide an accurate and relatively inex-
pensive assessment of the carotid arteries. The technique is
non-invasive and does not expose patients to ionizing ra-
diation or potentially nephrotoxic contrast material. B-
mode ultrasound has previously been used to identify high-
risk plaques by identifying plaque echolucency which has
been linked to future ischaemic events.39 In a study by
Nicolaides et al.14 ultrasound plaque features, including
124 M.K. Salem et al.GSM and plaque area, were independent predictors of
ipsilateral stroke risk in asymptomatic individuals. However,
no one (to date) has correlated computerized plaque ﬁnd-
ings with histology. The ACSRS study also found that
asymptomatic carotid stenosis and a history of contralateral
TIAs were independent predictors of future stroke risk. The
advantage of the current study is that it allows for predic-
tion of plaque histology using ultrasound plaque features.
At present, this predictive scoring system requires vali-
dation, but if it is shown to reliably identify unstable pla-
ques, it has the potential to select high-risk patients for
emergency surgery/stenting, whilst patients with a low
probability of having an unstable plaque may beneﬁt more
from medical therapy. An added advantage is that the al-
gorithm would also permit serial surveillance of plaque
morphology in patients treated medically.
In conclusion, this is one of the ﬁrst studies to show that
it might be possible to identify patients with a higher or
lower likelihood of having an unstable carotid plaque (on
histology) using accessible imaging technology.
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